These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10667318)

  • 21. Distinct influences of carboxyl terminal segment structure on function in the two isoforms of prostaglandin H synthase.
    Guo Q; Kulmacz RJ
    Arch Biochem Biophys; 2000 Dec; 384(2):269-79. PubMed ID: 11368314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Closing in on a stomach-sparing aspirin substitute.
    Service RF
    Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
    [No Abstract]   [Full Text] [Related]  

  • 23. [A heterogenous drug class. NSAID: classification and spectrum of action].
    Ulbrich H; Dannhardt G
    Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
    [No Abstract]   [Full Text] [Related]  

  • 24. High-field EPR study of tyrosyl radicals in prostaglandin H(2) synthase-1.
    Dorlet P; Seibold SA; Babcock GT; Gerfen GJ; Smith WL; Tsai AL; Un S
    Biochemistry; 2002 May; 41(19):6107-14. PubMed ID: 11994006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new mechanism of COX-2 in inflammation].
    Sano H
    Ryumachi; 2002 Jun; 42(3):560-72. PubMed ID: 12166110
    [No Abstract]   [Full Text] [Related]  

  • 26. [Selective cyclooxygenase 2 inhibitors (COX-2)].
    Mejza F; Nizankowska E
    Postepy Hig Med Dosw; 2001; 55(2):287-302. PubMed ID: 11468975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica.
    Dey I; Keller K; Belley A; Chadee K
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13561-6. PubMed ID: 14585927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats.
    Jones CJ; Budsberg SC
    J Am Vet Med Assoc; 2000 Sep; 217(5):721-9. PubMed ID: 10976307
    [No Abstract]   [Full Text] [Related]  

  • 29. Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations.
    Selinsky BS; Gupta K; Sharkey CT; Loll PJ
    Biochemistry; 2001 May; 40(17):5172-80. PubMed ID: 11318639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insights into the stereochemistry of the cyclooxygenase reaction.
    Kiefer JR; Pawlitz JL; Moreland KT; Stegeman RA; Hood WF; Gierse JK; Stevens AM; Goodwin DC; Rowlinson SW; Marnett LJ; Stallings WC; Kurumbail RG
    Nature; 2000 May; 405(6782):97-101. PubMed ID: 10811226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The productive conformation of arachidonic acid bound to prostaglandin synthase.
    Malkowski MG; Ginell SL; Smith WL; Garavito RM
    Science; 2000 Sep; 289(5486):1933-7. PubMed ID: 10988074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coupling between cyclooxygenases and prostaglandin F(2alpha) synthase. Detection of an inducible, glutathione-activated, membrane-bound prostaglandin F(2alpha)-synthetic activity.
    Nakashima K; Ueno N; Kamei D; Tanioka T; Nakatani Y; Murakami M; Kudo I
    Biochim Biophys Acta; 2003 Jul; 1633(2):96-105. PubMed ID: 12880869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity.
    Lanzo CA; Sutin J; Rowlinson S; Talley J; Marnett LJ
    Biochemistry; 2000 May; 39(20):6228-34. PubMed ID: 10821698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disputed role of COX-2 in myocardial infarction, is the jury still out?
    Patel HH; Gross GJ
    J Mol Cell Cardiol; 2002 Jan; 34(1):1-3. PubMed ID: 11812159
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular regulation of prostaglandin H synthase catalysis.
    Kulmacz RJ
    FEBS Lett; 1998 Jul; 430(3):154-7. PubMed ID: 9688529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression.
    Goppelt-Struebe M
    Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):213-22. PubMed ID: 7784467
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
    Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
    Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin.
    Ouellet M; Riendeau D; Percival MD
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14583-8. PubMed ID: 11717412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substitution of tyrosine for the proximal histidine ligand to the heme of prostaglandin endoperoxide synthase 2: implications for the mechanism of cyclooxygenase activation and catalysis.
    Goodwin DC; Rowlinson SW; Marnett LJ
    Biochemistry; 2000 May; 39(18):5422-32. PubMed ID: 10820014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
    Kozak KR; Prusakiewicz JJ; Rowlinson SW; Prudhomme DR; Marnett LJ
    Biochemistry; 2003 Aug; 42(30):9041-9. PubMed ID: 12885237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.